Central Plains Securities 240 million assets management products trample mines: the chairman of the board of directors leads the team to report to the public security

category:Finance
 Central Plains Securities 240 million assets management products trample mines: the chairman of the board of directors leads the team to report to the public security


In mid-late April, when the two phases of asset management products were about to expire, the project manager went to Fuzhou to meet the projects due repayment. As a financier, Minxing Pharmaceutical indicated that liquidity problems had arisen. Central Plains Securities then arranged for special personnel to visit Fuzhou to learn about the situation, to conduct multi-round consultations with the financiers, and to coordinate Huaxin Trust and other parties to urge the financiers to fulfil their repayment responsibilities.

In the process of repeated consultations, Zhongyuan Securities found that Xia Xuewen, the actual controller of Minxing Pharmaceutical Company, had lost contact. Central Plains Securities Chairman Kan Mingjun immediately personally led the team to report to the Henan Public Security Bureau. At present, the matter has been put on file, and the public security organs have started related work. According to the latest information, Xia Xuewen, the actual controller of Minxing Medicine, has been detained by Fuzhou Public Security Bureau.

It is worth mentioning that on the official website of the fund association, the operation status of the management products is usually normal operation, normal liquidation, or early liquidation, while the column of operation status of the two products mentioned above shows FS09. After inquiring about another securities firms products facing a cash crisis, Pengchao News found that its operation status is also FS09.

The investment target of these two products is Fujian Minxing Pharmaceutical Co., Ltd. According to Tian Eye Check data, Fujian Minxing Pharmaceutical was registered with Fujian Administration for Industry and Commerce on July 30, 1994. The legal representative is Xia Xuewen. The companys business scope includes traditional Chinese medicine, western medicine, medical supplies and equipment, chemical products (excluding dangerous chemicals and precursor chemicals).

On July 7, 2016, Minxing Pharmaceutical Company was sued for private loan disputes.

In particular, on May 13, 2019, the civil ruling issued by the Wuxi Intermediate Peoples Court of Jiangsu Province showed that the property of Minxing Pharmaceutical Company had been preserved by the League of Nations Trust.

According to disclosure, Guolian Trust Co., Ltd. filed an application for pre-litigation property preservation on May 13, 2019 for freezing bank deposits of RMB 360 million in Fujian Medical University Affiliated Union Medical Hospital and Fujian Fujian Fujian Minxing Medical Co., Ltd. or sealing up or seizing other equivalent property, and has provided property. Among them, Fujian Minxing Pharmaceutical Co., Ltd. has creditors rights receivable to Fujian Medical University Affiliated Union Medical Hospital, Fujian Cancer Hospital, Fujian Provincial Hospital, Fujian Medical University Affiliated First Hospital, Fujian Peoples Armed Police Force Fujian Provincial Headquarters Hospital.

At present, there is no ruling on property preservation of Minxing Pharmaceutical Co., Ltd. by Zhongyuan Securities Application on the Internet of Judgment Documents.

It is understood that the Central Plains Securities has set up a special risk mitigation work leading group to actively respond to risk incidents. The company has set up a leading group headed by Chairman Kan Mingjun and President Chang Junsheng, to coordinate and coordinate the deployment arrangements from the aspects of basic assets recovery and customer stability. At the same time, the company is also vigorously pursuing basic assets. On the one hand, it cooperates with the public security organs to carry out relevant work. On the other hand, it organizes key personnel to go to Fuzhou and other places to actively communicate and negotiate with Huaxin Trust, Fujian Xing Pharmaceutical and related units and personnel. It tries to increase repayment security by preserving assets and increasing credit. The work of recourse through civil litigation is also accumulated. Preparations are under way.

Zhongyuan Securities (601375), headquartered in Zhengzhou City, Henan Province, was listed on the Shanghai Stock Exchange on January 3, 2017. Before landing on the A-share market, Zhongyuan Securities had been listed on the Hong Kong Stock Exchange. The stock is referred to as Zhongzhou Securities (01375.HK). As a result, Zhongyuan Securities has become one of the A+H securities firms.

The controlling shareholder of Zhongyuan Securities is Henan Investment Group, with a share-holding ratio of 21.27%, which belongs to the government of Henan Province. In recent years, Zhongyuan Securities has absorbed a number of former supervisors as senior managers. In March 2018, Changjun, the former vice-director of the issuance department of the SFC, was competent to be the Vice-Secretary of the Party Committee of Central Plains Securities, and then took over the post of president. In January 2019, Zhao Huiwen, the former head of six departments of the SFC, joined Zhongyuan Securities as vice-president. According to the recent performance data of Central Plains Securities, the business income in June was 135 million yuan, a slight decline of 2.94% compared with the previous year; in the first half, the total business income reached 810 million yuan, an increase of 52.69% over the previous year; in the first half, the cumulative net profit was 191 million yuan, an increase of 123.61% over the previous year. Source: Wang Xiaowu_NF, Responsible Editor of Peng Mei News

The controlling shareholder of Zhongyuan Securities is Henan Investment Group, with a share-holding ratio of 21.27%, which belongs to the government of Henan Province.

In recent years, Zhongyuan Securities has absorbed a number of former supervisors as senior managers. In March 2018, Changjun, the former vice-director of the issuance department of the SFC, was competent to be the Vice-Secretary of the Party Committee of Central Plains Securities, and then took over the post of president. In January 2019, Zhao Huiwen, the former head of six departments of the SFC, joined Zhongyuan Securities as vice-president.

According to the recent performance data of Central Plains Securities, the business income in June was 135 million yuan, a slight decline of 2.94% compared with the previous year; in the first half, the total business income reached 810 million yuan, an increase of 52.69% over the previous year; in the first half, the cumulative net profit was 191 million yuan, an increase of 123.61% over the previous year.